GSK3B and chronic kidney disease: To this end, we used an adenine‐induced CKD model, GSK‐3β+/− mice, and lithium chloride (LiCl), a known inhibitor of GSK‐3 (Ryves and Harwood 2001) in our in vivo model and evaluated the effects of GSK‐3β repression on bone volume and parameters assessed using microcomputed tomography (micro‐CT).